New Schedule 2 Controlled Drugs
Amineptine and Tapentadol are now classified as Schedule 2Controlled Drugs under the Misuse of Drugs Regulations 2001. Neither iscurrently available in the UK.
Tapentadol, a recently developed centrally acting analgesic,is likely to be marketed in the UK shortly, according to the RoyalPharmaceutical Society, which added that it is not aware of any outstandingapplications for a marketing authorisation for amineptine.
The Regulations that underpin the classification came intoforce on 28 March 2011.
Citation: The Pharmaceutical Journal URI: 11072237
Recommended from Pharmaceutical Press